Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • The Pin-point™ platform: A novel modular base editing system
Interchanging-Cas-enzymes-deaminases-and-aptamer-guide-RNA1920x640.jpg
Brochure

The Pin-point™ platform: A novel modular base editing system

This presentation provides an overview of the Pin-point™ base editing platform with its novel three-part design and strong safety profile that enhances base editing's capabilities by enabling simultaneous modification of several genes at once, expanding its application in human disease modeling.

You will learn about:

  • The key benefits of the Pin-point base editing platform
  • How it works and differs from CRISPR gene editing
  • Supporting data

The Pin-point platform technology is available for clinical study and commercialization under a commercial license from Revvity. Pin-point reagents are available for research use only.

Download Resource

The Pin-point™ platform: A novel modular base editing system

Download Brochure
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.